Images List Premium Download Classic

Pathologic

Pathologic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for diagnosis, prognosis and methods of treatment
Nodality, Inc.
October 12, 2017 - N°20170292946

The invention provides methods, compositions, and systems for diagnosis, prognosis, evaluation of status, and/or determination of treatment for pathological conditions.
Antibodies specific for il-17a fused to hyaluronan binding peptide tags
Novartis Ag
October 12, 2017 - N°20170291939

The present disclosure relates to antibodies and proteins comprising an antigen-binding portion thereof that specifically bind to the pro-inflammatory cytokine il-17a and a peptide tag that binds hyaluronan (ha). The disclosure more specifically relates to specific antibodies and proteins that are il-17a antagonists (inhibit the activities of il-17a and il-17af) and are capable of inhibiting il-17...
Combination therapies for the treatment of alzheimer's disease and related disorders
The General Hospital Corporation
October 12, 2017 - N°20170290797

The present invention relates to combination therapies for treating alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective amount of a first compound, and a therapeutically effective amount of a second compound. In certain embodiments, the first compound or the second compound inhibits ab peptide polymerization; is an anti-inflammatory; improves cognitive function, mood, or social behavior; is ...
Pathologic Patent Pack
Download 207+ patent application PDFs
Pathologic Patent Applications
Download 207+ Pathologic-related PDFs
For professional research & prior art discovery
inventor
  • 207+ full patent PDF documents of Pathologic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for preparing liquid-state dripping or coating pathological quality control product and uses thereof
The General Hospital Corporation
October 05, 2017 - N°20170284909

Provided are a method for preparing a liquid-state dripping or coating pathological quality control product, and uses thereof. The method comprises: selecting and determining a control with a control value, and processing the control; adding an ethanol solution to the processed control for preserving for standby use, with the amount of the ethanol solution added depending on the amount of ...
Sytems and methods for display of pathological data in an image guided prodedure
Intuitive Surgical Operations, Inc.
October 05, 2017 - N°20170281139

A method comprises displaying an image of a patient anatomy for guiding a medical instrument to a deployment location during a medical procedure. The method further comprises recording a first sample identifier for a first tissue sample. The method also comprises receiving first tissue sample pathology information about the first tissue sample. The method also comprises displaying the first sample ...
Therapeutic and research application of pdcl3
Trustees Of Boston University
September 28, 2017 - N°20170274075

Described herein are novel compositions comprising, for example, pdcl3 polypeptides having vegfr-2 inhibitory activity, inhibitory pdcl3 antibodies and pdcl3-binding fragments thereof, or pdcl3 inhibitory nucleic acid molecules, and methods of their use in anti-angiogenesis and anti-tumor proliferation and invasiveness therapies, such as the treatment of cancer, as well as the treatment of those vascular diseases where pathological angiogenesis plays ...
Pathologic Patent Pack
Download 207+ patent application PDFs
Pathologic Patent Applications
Download 207+ Pathologic-related PDFs
For professional research & prior art discovery
inventor
  • 207+ full patent PDF documents of Pathologic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Silent fc variants of anti-cd40 antibodies
Novartis Ag
September 21, 2017 - N°20170267772

The present invention relates to silent fc variants of anti-cd40 antibodies and compositions and methods of use of said antibodies for treating pathological disorders such as autoimmune and inflammatory disorders and/or for preventing or reducing the risk of graft rejection in transplantation.
Vascular endothelial growth factor antagonists
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services
September 21, 2017 - N°20170267735

The present invention provides variant vegf polypeptides which have been altered in their c-terminal heparin binding region to lower their heparin binding affinity. These variants have been found to act as receptor antagonists for vegf receptors and antagonize angiogenesis. These variants are useful to treat diseases characterized by pathological angiogenesis.
Medicament carrier for the treatment and prevention of pathological conditions in the urogenital region
Urobrain Gmbh
September 21, 2017 - N°20170266423

The application relates to a medicament carrier which is suitable for the treatment and prevention of pathological conditions in the urogenital region of a person, in particular in the area of the urethra. Said medicament carrier comprises a biocompatible material that cannot melt at the person's body temperature. The medicament carrier is prepared, e. G. At least partially coated, with ...
Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
Indiana University Research And Technology Corporation
September 21, 2017 - N°20170266253

Methods are disclosed herein for administering a foxm1 inhibitor for preventing, treating, and/or reducing cardiac hypertrophy and/or cardiac failure. Particularly, the methods are directed to the use of a foxm1 inhibitor to block the function of foxm1-brg1 complex, thereby reversing the ace/ace2 expression ratio such to protect the heart from hypertrophy and failure.
Sustained-release formulations of topiramate
Supernus Pharmaceuticals, Inc.
September 21, 2017 - N°20170266121

Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is ...
Targeted elimination of bacterial genes
Technology Innovation Momentum Fund (isreal) Limited Partnership
September 14, 2017 - N°20170260546

Provided is a kit or a system including two elements or components. The first component (i) is a selective component including a nucleic acid sequence and at least one proto-spacer. The second component (ii) includes at least one sensitizing component including at least one cas gene and at least one crispr array. At least one spacer of the crispr targets ...
Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
Pharosgen
September 14, 2017 - N°20170260278

Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (pah), neoplasms and neoplasm-related conditions, and for detecting doppel expression in a subject. Related compositions and methods also are described.
Pathologic Patent Pack
Download 207+ patent application PDFs
Pathologic Patent Applications
Download 207+ Pathologic-related PDFs
For professional research & prior art discovery
inventor
  • 207+ full patent PDF documents of Pathologic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Podiatric pressure unloading device
Jason Hammond, Md, Llc
September 14, 2017 - N°20170258620

A pressure unloading device for unloading pressure on a pathological prominence of the foot includes a securement and a spacer. The securement wraps around a portion of a foot and secures a spacer to a region of the foot proximate to a pathological prominence in order to unload pressure on the prominence. Pressure unloading devices can further include footwear, such ...
Compositions and methods for treating pathological calcification and ossification
Yale University
September 07, 2017 - N°20170252414

The present invention includes compositions and methods for treating disease and disorders associated with pathological calcification or pathological ossification by modulating the level or activity of npp1 or a mutant thereof, or a mutant npp4 modified to exhibit atp hydrolase activity similar to the hydrolase activity of npp1.
Compositions and methods for transplantation of colon microbiota
Regents Of The University Of Minnesota
September 07, 2017 - N°20170252378

The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in ...
Regents Of The University Of Minnesota
September 07, 2017 - N°20170252308

A method is disclosed for reducing the extent of myocardial cell damage or cell death arising from hypoxia or a loss, reduction or interruption in coronary blood flow comprising administering a pharmaceutical composition which includes riluzole or a pharmaceutically acceptable salt or derivative thereof. The method further discloses administering the pharmaceutical composition to reduce the incidence and severity of arrhythmias ...
Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof
Arromax Pharmatech Co., Ltd.
August 31, 2017 - N°20170247339

Disclosed are a quinazoline derivative, a preparation method therefor, and a pharmaceutical composition and an application thereof. The present invention provides a compound represented by general formula i, a stereoisomer thereof and a pharmaceutical acceptable salt or a solvate thereof. The quinazoline derivative of the present invention has a unique chemical structure, is characterized by irreversibly inhibiting egfr tyrosine kinase, ...
Radioactive therapeutic device with fixation
Spec Med Intellectual Property, Llc
August 31, 2017 - N°20170246476

Devices and techniques for permanent application of radioactive sources in the field of brachytherapy are described. In an embodiment, an implantable device for radiation therapy of pathological tissues directed toward the administration of radiation to tissue adjacent a cavity wall or surgical excision. The device may include an insertable member, such as a substantially cylindrical member, having at least two ...
Compositions and methods for transplantation of colon microbiota
Regents Of The University Of Minnesota
August 31, 2017 - N°20170246214

The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses ...
Commissariat A L'energie Atomique Et Aux Energies Alternatives
August 24, 2017 - N°20170242034

The invention relates to a method for in vitro investigating mitochondrial replication dysfunction in a biological sample removed from a subject susceptible of suffering from physiological ageing or physiopathological conditions related to physiological ageing, or physiopathological ageing or associated symptoms or conditions, in particular premature ageing or accelerated ageing, or of a progeroid syndrome, such as cockayne syndrome (cs), or ...
Loading